Search by Drug Name or NDC
NDC 00781-3431-46 Linezolid 200 mg/100mL Details
Linezolid 200 mg/100mL
Linezolid is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is LINEZOLID.
MedlinePlus Drug Summary
Linezolid injection is used to treat infections, including pneumonia, and infections of the skin. Linezolid is in a class of antibacterials called oxazolidinones. It works by stopping the growth of bacteria. Antibiotics such as linezolid injection will not kill viruses that can cause colds, flu, or other infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 00781-3431-46Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Linezolid Injection
Product Information
| NDC | 00781-3431 |
|---|---|
| Product ID | 0781-3431_69427822-65b5-4d23-ae45-82dc703208f5 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Linezolid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Linezolid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/100mL |
| Substance Name | LINEZOLID |
| Labeler Name | Sandoz Inc |
| Pharmaceutical Class | Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA200904 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00781-3431-46 (00781343146)
| NDC Package Code | 0781-3431-46 |
|---|---|
| Billing NDC | 00781343146 |
| Package | 100 mL in 1 BAG (0781-3431-46) |
| Marketing Start Date | 2016-06-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |